Dr Reddy's Laboratories (NYSE: RDY)
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-26 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.550 | 0.070 | -0.4800 | ||||
REV | 722.931M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Dr Reddy's Laboratories (NYSE: RDY) through any online brokerage.
Other companies in Dr Reddy's Laboratories’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Dr Reddy's Laboratories (NYSE: RDY) was reported by Barclays on Tuesday, May 24, 2022. The analyst firm set a price target for 70.00 expecting RDY to rise to within 12 months (a possible 25.36% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Dr Reddy's Laboratories (NYSE: RDY) is $55.84 last updated July 1, 2022, 7:59 PM UTC.
The next Dr Reddy's Laboratories (RDY) dividend date is projected to be Friday, July 8, 2022.
Dr Reddy's Laboratories’s Q1 earnings are confirmed for Tuesday, July 26, 2022.
There is no upcoming split for Dr Reddy's Laboratories.
Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.